Rapid Communications in Mass Spectrometry · 2009 · 130 citations · 24 references
PharmacyChemistryPharmaceutical AnalysisAnalytical ChemistryMass Spectrometric AnalysisMetabolomicsBioanalytical Method ValidationInstrumental AnalysisMass AnalyzersMass SpectrometryMetabolite QuantificationSmall Molecule AnalysisMass Spectrometric DetectionMass Spectrometric Drug AnalysisMass Spectrometric QuantificationPrecisionPreclinical Drug DevelopmentQuantification Of AnalytesSelected Reaction MonitoringTandem Mass Spectrometry Analysis
High‑resolution mass spectrometry in full‑scan mode eliminates the need for MS/MS optimization, unlike SRM‑based tandem MS detection. The study evaluated the quantitative performance of a linear ion trap Orbitrap mass spectrometer in full‑scan mode at a mass resolution of 15 000. Quantitation was performed by generating extracted ion chromatograms with ±5–10 mmu windows around theoretical m/z values, and the Orbitrap’s performance was benchmarked against a triple‑quadrupole SRM system, with an example of metabolite identification in a preclinical study. Both methods showed comparable precision, accuracy, linearity, and sensitivity, with statistically equivalent concentrations for 15 Merck drug candidates, and the full‑scan approach also yielded data on additional analytes. © 2009 John Wiley & Sons, Ltd.
Abstract The quantitative capabilities of a linear ion trap high‐resolution mass spectrometer (LTQ‐Orbitrap™) were investigated using full scan mode bracketing the m/z range of the ions of interest and utilizing a mass resolution (mass/FWHM) of 15000. Extracted ion chromatograms using a mass window of ±5–10 mmu centering on the theoretical m/z of each analyte were generated and used for quantitation. The quantitative performance of the LTQ‐Orbitrap™ was compared with that of a triple quadrupole (API 4000) operating using selected reaction monitoring (SRM) detection. Comparable assay precision, accuracy, linearity and sensitivity were observed for both approaches. The concentrations of actual study samples from 15 Merck drug candidates reported by the two methods were statistically equivalent. Unlike SRM being a tandem mass spectrometric (MS/MS)‐based detection method, a high resolution mass spectrometer operated in full scan does not need MS/MS optimization. This approach not only provides quantitative results for compounds of interest, but also will afford data on other analytes present in the sample. An example of the identification of a major circulating metabolite for a preclinical development study is demonstrated. Copyright © 2009 John Wiley & Sons, Ltd.
24
Andrew D. Southam, Tristan G. Payne, Helen J. Cooper et al. · Analytical Chemistry · 2007 · 195 citations
Mark Wrona, Timo Mauriala, Kevin P. Bateman et al. · Rapid Communications in Mass Spectrometry · 2005 · 174 citations